Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis

Silva1, Sofia Campos; Barroso2, Andreia; Cunha3, Maria; Fragoso4,5, Elsa; Azevedo4,5, Pilar

doi:https://dx.doi.org/10.36416/1806-3756/e20240406

7172
Views

Back to summary

Open Access

Peer-Reviewed
Original Article

Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis

Sofia Campos Silva1, Andreia Barroso2, Maria Cunha3, Elsa Fragoso4,5, Pilar Azevedo4,5

DOI: https://dx.doi.org/10.36416/1806-3756/e20240406

1. Hospital Beatriz Ângelo, ULS Loures-Odivelas, Loures, Portugal.
2. Hospital de Faro, ULS do Algarve, Faro, Portugal.
3. Hospital de Vila Franca de Xira, ULS Estuário do Tejo, Vila Franca de Xira, Portugal.
4. Hospital de Santa Maria, ULS de Santa Maria, Lisboa, Portugal.
5. Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Submitted: 12 December 2024.
Accepted: 12 February 2025.
Study carried out at the Centro de Referência de Fibrose Quística, Hospital de Santa Maria, Lisboa, Portugal.

Correspondence to:
Sofia Campos Silva. Avenida Carlos Teixeira, 3, 2674-514, Loures, Portugal.
Tel.: 351 21 984 7200. E-mail: ana.campos.silva@ulslod.min-saude.pt
Financial support: None.